Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients
CompletedOBSERVATIONAL
Enrollment
43
Participants
Timeline
Start Date
July 19, 2021
Primary Completion Date
May 16, 2022
Study Completion Date
November 16, 2022
Conditions
SARS-Cov-2 InfectionRheumatoid Arthritis
Interventions
OTHER
Blood sampling
Blood sampling - 10mL
Trial Locations (1)
34080
CHU Montpellier, Montpellier
All Listed Sponsors
lead
University Hospital, Montpellier
OTHER
NCT04880720 - Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter